THBD and atherosclerosis: Several studies report that the level of KLF2 in ECs plays anti-inflammatory and anti-thrombosis roles in atherosclerosis by enhancing the generation of anti-inflammatory and anti-coagulant molecules, including thrombomodulin (TM) and eNOS.